Article
San Francisco - Two large phase III studies involving 15 percent azelaic gel (Finacea) for the treatment of rosacea each resulted in more than a 50-percent reduction in the number of lesions.
CT-P39 is Just as Effective as Omalizumab for Chronic Spontaneous Urticaria Treatment
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
James Del Rosso, DO, on What’s New in the Medicine Chest
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Exploring Oral Therapies for Hyperhidrosis: Current and Future Perspectives
Developing an OTC Dermatology Product